Download PDF
Der Klinikarzt 2005; 34(11): 332-335
DOI: 10.1055/s-2005-923520
In diesem Monat

© Georg Thieme Verlag Stuttgart · New York

Koinfektionen und gegenseitige Beeinflussung - Sexuell übertragbare Krankheiten und HIV

Coinfections and Affecting Conditions - Sexually Transmitted Diseases and HIVM. Hartmann1
  • 1Universitäts-Hautklinik Heidelberg (Direktor: Prof. Dr. A. Enk)
Further Information

Publication History

Publication Date:
01 December 2005 (online)

Also available at
   Permissions and Reprints

Zusammenfassung

HIV-Infektionen und sexuell übertragene Erkrankungen treten häufig gemeinsam auf oder erhöhen gegenseitig das Risiko der Infektion. Dies betrifft vor allem sexuell übertragbare Krankheiten, die mit Ulzerationen verlaufen wie Syphilis, Herpes genitoanalis, Ulcus molle, Granuloma inguinale und Lymphogranuloma vernereum. Eine gleichzeitig bestehende unbehandelte HIV-Infektion beeinflusst besonders den Verlauf der Syphilis.

Summary

HIV infection and sexually transmitted diseases are frequent coinfections. That concerns especially patients with genital ulcer diseases (Syphilis, Herpes genitalis, Chancroid, Donovanosis and Lymphogranuloma vernereum). Patients with syphilis and untreated HIV-infection have uncommon manifestations and therapy failure of the treponemal infection.

Key Words

sexually transmitted diseases - HIV - syphilis

Literatur

  • 1 Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection.  Sex Transm Infect. 1999;  75 3-17
    PubMedSearch in Google Scholar
  • 2 Grosskurth H, Gray R, Hayes R. et al. . Control of sexually transmitted diseases for HIV-1 prevention: understanding the implications of the Mwanza and Rakai trials.  Lancet. 2000;  355 1981-1987
    CrossrefPubMedSearch in Google Scholar
  • 3 Price MA, Zimba D, Hoffman IF. et al. . Addition of treatment for trichomoniasis to syndromic management of urethritis in Malawi: a randomized clinical trial.  Sex Transm Dis. 2003;  30 516-522
    PubMedSearch in Google Scholar
  • 4 Recommendations for incorporating human immunodeficiency virus (HIV) prevention into the medical care of persons living with HIV.  Clin Infect Dis. 2004;  38 104-121
    CrossrefPubMedSearch in Google Scholar
  • 5 Risbud A. Human immunodeficiency virus (HIV) & sexually transmitted diseases (STDs).  Indian J Med Res. 2005;  121 369-376
    PubMedSearch in Google Scholar
  • 6 Schofer H, Imhof M, Thoma-Greber E. et al. . Active syphilis in HIV infection: a multicentre retrospective survey. The German AIDS Study Group (GASG).  Genitourin Med. 1996;  72 176-181
    PubMedSearch in Google Scholar
  • 7 Centers for Disease Control and Prevention. . Sexually transmitted diseases treatment guidelines 2002.  MMWR Recomm Rep. 2002;  51 1-78
    PubMedSearch in Google Scholar
  • 8 Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis.  J Infect Dis. 2002;  185 45-52
    CrossrefPubMedSearch in Google Scholar
  • 9 Wasserheit JN. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases.  Sex Transm Dis. 1992;  19 61-77
    PubMedSearch in Google Scholar
  • 10 Wawer MJ, Gray RH, Sewankambo NK. et al. . Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection in Rakai, Uganda.  J Infect Dis. 2005;  191 1403-1409
    CrossrefPubMedSearch in Google Scholar

Anschrift des Verfassers

Dr. Martin Hartmann

Universitäts-Hautklinik

Voß-Str. 2

69115 Heidelberg